Neuren Pharmaceuticals LimitedASX: NEU

Neuren granted Type B Meeting with FDA for Rett syndrome

Jul 20, 2017 at 7:05 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment